218 related articles for article (PubMed ID: 10575503)
1. [Severe anaphylactic reactions after administration of rocuronium].
Barthelet Y; Ryckwaert Y; Plasse C; Bonnet-Boyer MC; d'Athis F
Ann Fr Anesth Reanim; 1999 Oct; 18(8):896-900. PubMed ID: 10575503
[TBL] [Abstract][Full Text] [Related]
2. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
Pedersen AF; Green S; Rose MA
Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
[TBL] [Abstract][Full Text] [Related]
3. Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital.
Brereton A; Russell WJ
Anaesth Intensive Care; 2012 Sep; 40(5):861-6. PubMed ID: 22934871
[TBL] [Abstract][Full Text] [Related]
4. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
[TBL] [Abstract][Full Text] [Related]
5. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex and rocuronium-induced anaphylaxis.
Takazawa T; Mitsuhata H; Mertes PM
J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
[TBL] [Abstract][Full Text] [Related]
7. [Muscle relaxants in the ICU].
Schneider G
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
[TBL] [Abstract][Full Text] [Related]
8. Differentiating the cellular and humoral components of neuromuscular blocking agent-induced anaphylactic reactions in patients undergoing anaesthesia.
Aalberse RC; Kleine Budde I; Mulder M; Stapel SO; Paulij W; Leynadier F; Hollmann MW
Br J Anaesth; 2011 May; 106(5):665-74. PubMed ID: 21414980
[TBL] [Abstract][Full Text] [Related]
9. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events.
Bhananker SM; O'Donnell JT; Salemi JR; Bishop MJ
Anesth Analg; 2005 Sep; 101(3):819-822. PubMed ID: 16115997
[TBL] [Abstract][Full Text] [Related]
10. Rocuronium: high risk for anaphylaxis?
Rose M; Fisher M
Br J Anaesth; 2001 May; 86(5):678-82. PubMed ID: 11575345
[TBL] [Abstract][Full Text] [Related]
11. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide.
Ebo DG; Bridts CH; Hagendorens MM; Mertens CH; De Clerck LS; Stevens WJ
Allergy; 2006 Aug; 61(8):935-9. PubMed ID: 16867045
[TBL] [Abstract][Full Text] [Related]
12. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
13. Anaphylactic reactions to suxamethonium (succinylcholine).
Villas Martínez F; Joral A; Garmendia FJ; Navarro JA
J Investig Allergol Clin Immunol; 1999; 9(2):126-8. PubMed ID: 10353102
[TBL] [Abstract][Full Text] [Related]
14. Rocuronium anaphylaxis in a 3-year-old girl with no previous exposure to neuromuscular blocking agents.
Choi SH; Yi JW; Rha YH
Asian Pac J Allergy Immunol; 2013 Jun; 31(2):163-6. PubMed ID: 23859417
[TBL] [Abstract][Full Text] [Related]
15. Modification of mediators of immune reaction after general anaesthesia.
Sánchez Palacios A; Ortiz Ponce M; Rodríguez Pérez A; Schamann Medina F; García Marrero JA
Allergol Immunopathol (Madr); 2004; 32(6):352-60. PubMed ID: 15617663
[TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
Dewachter P; Mouton-Faivre C
Anesthesiology; 2015 Sep; 123(3):735-6. PubMed ID: 26284871
[No Abstract] [Full Text] [Related]
17. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661
[TBL] [Abstract][Full Text] [Related]
18. [Anaphylactic shock caused by pancuronium and vecuronium].
Conil C; Bornet JL; Jean-Noel M; Conil JM; Brouchet A
Ann Fr Anesth Reanim; 1985; 4(2):241-3. PubMed ID: 2860830
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool.
Ebo DG; Venemalm L; Bridts CH; Degerbeck F; Hagberg H; De Clerck LS; Stevens WJ
Anesthesiology; 2007 Aug; 107(2):253-9. PubMed ID: 17667569
[TBL] [Abstract][Full Text] [Related]
20. Anaphylactic reactions to rocuronium.
Laxenaire MC; Moneret-Vautrin DA
Br J Anaesth; 2000 Aug; 85(2):325-6. PubMed ID: 10992851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
